A recent review provides evidence for probiotic use in liver disease.
It is rare that a single point of treatment or modality is adequate to mitigate risk or resolve illnesses. As such, a multipoint approach is attractive and necessary.
CoQ10 is a well-known antioxidant, active in every cell of the body. It has a strong link with cellular mitochondria and may also have a crucial role in mitochondrial homeostasis and therefore down-regulation of inflammasomes.
With the help of Dr Mark Donohoe, we will unpack the learning points from the 2015 BioCeuticals Symposium and it's themes of Oxidation, Inflammation and Immune Dysfunction.
Dr Donohoe also touches on the challenges facing modern medicine in the changing terrain of patients who don't fit into a "well-described diagnostic box".
This podcast explores the clinical implications and practical implementation gleaned from the speakers at the 2015 BioCeuticals Symposium. With so much information to revisit, this may be the first of a series.
